# OnCo record second-primary-lung-after-chest-radiotherapy (term). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/terms/second-primary-lung-after-chest-radiotherapy/>
  a schema:DefinedTerm ;
  onco:kind "term" ;
  schema:identifier "second-primary-lung-after-chest-radiotherapy" ;
  schema:name "Lung cancer after chest radiotherapy and after alkylating chemotherapy"@en ;
  schema:alternateName "Second primary lung cancer"@en, "Lung cancer after Hodgkin lymphoma"@en, "Lung cancer after breast radiotherapy"@en ;
  schema:description "Lung cancer is the commonest cause of death among people who develop a second cancer, and chest radiotherapy raises the risk of it for more than twenty years. There is no screening programme aimed at survivors anywhere, although some survivor groups have a measured rate above the threshold at which lung screening was shown to save lives, so this is a gap rather than a settled answer."@en ;
  schema:url <https://onco.cc/terms/second-primary-lung-after-chest-radiotherapy/> ;
  schema:dateModified "2026-10-02"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Lung_cancer_screening> ;
  schema:citation <https://doi.org/10.1093/jnci/94.3.182>, <https://doi.org/10.1016/j.radonc.2014.10.004>, <https://doi.org/10.1016/j.radonc.2016.08.017>, <https://doi.org/10.1007/s10552-019-01161-7>, <https://doi.org/10.1002/cncr.30164> ;
  onco:tag "rejuvenation", "survivorship", "second-cancers", "lung", "radiotherapy", "smoking" ;
  onco:related <https://onco.cc/terms/rejuv-second-age-smoking-and-inherited-risk/>, <https://onco.cc/terms/rejuv-second-radiotherapy-dose-field-and-age/>, <https://onco.cc/terms/rejuv-second-screening-after-treatment-compared/>, <https://onco.cc/terms/rejuv-second-cancers-overview/> ;
  onco:cancers <https://onco.cc/cancers/lung-cancer/>, <https://onco.cc/cancers/nsclc/>, <https://onco.cc/cancers/hodgkin-lymphoma/>, <https://onco.cc/cancers/breast-cancer/>, <https://onco.cc/cancers/head-and-neck/>, <https://onco.cc/cancers/oropharyngeal-cancer/>, <https://onco.cc/cancers/urothelial/>, <https://onco.cc/cancers/esophageal/> ;
  onco:sections <https://onco.cc/fronts/rejuvenation/>, <https://onco.cc/fronts/supportive-care/>, <https://onco.cc/fronts/prevention/> ;
  onco:technologies <https://onco.cc/technologies/low-dose-ct-screening/>, <https://onco.cc/terms/smoking-cessation/>, <https://onco.cc/technologies/survivorship-care-plan/> ;
  onco:terms <https://onco.cc/terms/secondary-malignancy/>, <https://onco.cc/terms/second-cancers-after-radiotherapy/>, <https://onco.cc/terms/late-effects/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-early-detection/>, <https://onco.cc/bottlenecks/b-survivorship/>, <https://onco.cc/bottlenecks/b-prevention-adoption/> .